New Medication for High-Risk Populations Could Reduce the Health and Economic Burden of Heart Disease

Ottawa, April 27, 2017— Heart disease is the leading cause of death among Canadians and is one of the main reasons for hospitalizations and disability in Canada. Cardiovascular disease prevalence and mortality represent significant costs to public governments and society due to hospitalizations, disease management, and lost productivity in Canada.

Visit the Conference Board of Canada for the complete article